Intracerebroventricular drug administration was performed as reported previously20 (link)–21 (link). A burr hole was drilled into the skull according to the following coordinates relative to bregma: 1.5 mm posterior and 1.0 mm lateral. The needle of a 10µL Hamilton syringe (Microliter 701; Hamilton Company, Reno, NV) was inserted through the burr hole into the left lateral ventricle through the burr hole 4.0 mm below the horizontal plane of bregma. Sterile PBS vehicle or 5ul rOPN (0.1ng in 5ul; EMD Chemicals, La Jolla, CA) were administered 3 hours after SAH induction by a pump at a rate of 0.5 ul /min., respectively. GRGDSP (Sigma-Aldrich, St. Louis, MO; 100pmol in 1uL), Fib-14 (Tocris Bioscience, Ellisville, MI; 0.2 mg in 5 µL PBS) or NSC23766 (Santa Cruz Biotechnology; 30ug/5ul) was administered 1 hour before SAH induction. 500 pmol/5ul ILK siRNA or scrambled siRNA (Life Technologies) was infused at the same rate 48 hours before SAH modeling.